NCT00239499 - Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

107

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium

DRUG

Salmeterol plus Fluticasone

Trial Locations (12)

Centre for Chest Diseases Research Unit, Johannesburg

Durban Lung Centre, Durban

St Augustine Hospital, Durban

QdotPharma, George

Vergelegen Medi-Clinic, Somerset West

Tijger Trial Centre, Bellville

Boehringer Ingelheim Investigational Site, Paarl

UCT Lung Institute, Cape Town

Boehringer Ingelheim Investigational Site, Cape Town

Boehringer Ingelheim Investigational Site, Bloemfontein

Boehringer Ingelheim Investigational Site, Welkom

Boehringer Ingelheim Investigational Site, Pretoria